ACQUISITION AGREEMENT AGREEMENT dated July 12, 2000, by, between and among LAREDO INVESTMENTS CORP., a company incorporated under the laws of the state of Nevada (hereinafter referred to as "Laredo") and having an address for service at 1800 E. Sahara...Acquisition Agreement • August 23rd, 2000 • Laredo Investment Corp • Non-operating establishments • British Columbia
Supplementary AgreementSupplementary Agreement • November 8th, 2011 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
Due to the overall changes in social medical industry, improvement in service consciousness and rapid development of medical technology, both parties agreed to purchase a large cancer examine equipment—a set of PETCT, which is to meet the development need of medical market, expend the scope of services and keep our long-term first-class technology, equipment and service brand, and further to ensure a stable income in competition of medical industry. Based on the signed “Agreement for Cooperation Establishment of Tangdu Gamma Knife Therapeutic Center”, “Agreement for Cooperation Establishment of Tangdu PET Diagnosis Center” and “Supplementary Agreement for Cooperative Establishment of Tangdu PET Diagnosis Center” and “Tangdu Gamma Knife Therapeutic Center” ( hereinafter referred to as the Cooperation Agreement) and in order to comply with the principles of friendly negotiation, mutual benefit and sharing the risk together, in terms of related information of the equipment, both parties c
LETTER OF INTENTLetter of Intent • August 31st, 2005 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
THIS BINDING LETTER OF INTENT (the “LOI”), is made this 12th day of August 2005, by GFR PHARMACEUTICALS INC. (“GFRP”), a Nevada corporation, Richard Pierce (“Pierce”), the president and majority shareholder of GFRP, and Harbin Yinhai Technology Development Company LTD (“YHT”), a corporation formed according to the laws of P.R.China. This LOI sets forth the terms and conditions upon which the parties will enter into binding agreements.
ESCROW AGREEMENTEscrow Agreement • July 3rd, 2006 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
THIS ESCROW AGREEMENT dated June 20, 2006 (this "Agreement"), is entered into by and among GFR Pharmaceuticals Inc., a Nevada corporation (“GFRP”), Richard Pierce, controlling shareholder of GFRP ("Pierce"), New Century Scientific Investment Ltd., a corporation formed according to the laws of P. R. China ("New Century"), Guo, Li An, controlling shareholder of New Century and representative of the selling shareholders of New Century (referred to collectively as "New Century"), and Greentree Financial Group, Inc. (the "Escrow Agent").
LETTER OF INTENTLetter of Intent • July 3rd, 2006 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
THIS BINDING LETTER OF INTENT (the “LOI”), is made this 6th day of June 2006, by GFR PHARMACEUTICALS INC. (“GFRP”), a Nevada corporation, Richard Pierce (“Pierce”), the president and majority shareholder of GFRP, New Century Scientific Investment Ltd . (“New Century”), a corporation formed according to the laws of P. R. China, and the majority shareholder of New Century (referred to collectively as the "New Century Shareholders"). This LOI sets forth the terms and conditions upon which the parties will enter into binding agreements.
PLAN OF EXCHANGE BY WHICH GFR PHARMACEUTICALS INC. (a Nevada corporation) SHALL ACQUIRE NEW CENTURY SCIENTIFIC INVESTMENT LTD. (a corporation organized under the laws of the Peoples’ republic of China)Plan of Exchange • July 3rd, 2006 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
ADJUSTMENTS: lead This Plan of Exchange (“Agreement” or “Plan of Exchange”) is made and dated as of this 26th day of June, 2006, and is intended to supersede all previous oral or written agreements, if any, between the parties, with respect to its subject matter. Notwithstanding the foregoing, it is subject to, and shall be interpreted together with the Letter of Intent, dated June 6, 2006 ("LOI"), and the Escrow Agreement, dated June 20, 2006 ("Escrow Agreement"). This Agreement anticipates that extensive due diligence shall have been performed by both parties.
Supplementary AgreementSupplementary Agreement • August 12th, 2011 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
Due to the overall changes in social medical industry, improvement in service consciousness and rapid development of medical technology, both parties agreed to purchase a large cancer examine equipment—a set of PETCT, which is to meet the development need of medical market, expend the scope of services and keep our long-term first-class technology, equipment and service brand, and further to ensure a stable income in competition of medical industry. Based on the signed “Agreement for Cooperation Establishment of Tangdu Gamma Knife Therapeutic Center”, “Agreement for Cooperation Establishment of Tangdu PET Diagnosis Center” and “Supplementary Agreement for Cooperative Establishment of Tangdu PET Diagnosis Center” and “Tangdu Gamma Knife Therapeutic Center” ( hereinafter referred to as the Cooperation Agreement) and in order to comply with the principles of friendly negotiation, mutual benefit and sharing the risk together, in terms of related information of the equipment, both parties c
Stock Equity Transfer supplemental AgreementStock Equity Transfer Agreement • May 20th, 2008 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
In accordance with “stock equity transfer agreement” signed by parties A and B on January 1, 2008, two parties have made the supplemental agreement on transferring the stock equity of Xi'an Jiaoda Bio-sep Bio-technology Co., Ltd. (hereinafter referred to as Bao Sai) owned by Party A to Party B ,via negotiation, the supplemental agreement is made as follows:
Cooperation Establishment of “Tangdu Gamma Knife Therapeutic Center” Agreement Tangdu Hospital Affiliated to Fourth Military Medical University Masep Medical Science & Technology Development (Shenzhen) Co., Ltd.Cooperation Agreement • April 14th, 2008 • GFR Pharmaceuticals Inc • Pharmaceutical preparations
